Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026)
Vanda Pharmaceuticals' (VNDA) quarterly EPS (Basic) came in at -$0.82 in Q1 2026, down 64.0% year-on-year from -$2.28 in Q1 2025, and up 65.69% quarter-over-quarter from -$2.39 in Q4 2025.
Vanda Pharmaceuticals (VNDA) EPS (Basic) (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.82 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.82, down 64.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.05 (down 432.89% YoY), and the FY2025 annual result was -$3.74, down 1033.33% from the prior year.
- EPS (Basic) came in at -$0.82 for Q1 2026 at Vanda Pharmaceuticals, up from -$2.39 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.12 in Q4 2022 to a low of -$2.39 in Q4 2025.
- The 5-year median for EPS (Basic) is -$0.08 (2024), against an average of -$0.28.
- Across the five-year window, EPS (Basic) jumped 154.55% in 2023 and tumbled 3866.2% in 2024, its largest moves.
- Vanda Pharmaceuticals' EPS (Basic) stood at $0.12 in 2022, then tumbled by 141.67% to -$0.05 in 2023, then plunged by 80.0% to -$0.09 in 2024, then plunged by 2555.56% to -$2.39 in 2025, then jumped by 65.69% to -$0.82 in 2026.
- The last three EPS (Basic) figures came in at -$0.82 (Q1 2026), -$2.39 (Q4 2025), and -$0.38 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -2.39 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | 0.13 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.17 |